1932

Abstract

The molecular elucidation of two human skeletal dysplasias revealed that they are caused by an increase or a decrease in the synthesis of serotonin by enterochromaffin cells of the gut. This observation revealed a novel and powerful endocrine means to regulate bone mass. Exploiting these findings in the pharmacological arena led to the demonstration that inhibiting synthesis of gut-derived serotonin could be an effective means to treat low-bone-mass diseases such as osteoporosis.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-090710-133426
2011-02-18
2024-03-28
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-med-090710-133426
Loading
/content/journals/10.1146/annurev-med-090710-133426
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error